Axonics MOAB

Study Purpose

The purpose of this research is to evaluate if the Axonics SNM System reduces urinary urgency incontinence (UUI) symptoms in male patients who have had a prostatectomy for prostate cancer, radiation therapy for prostate cancer, or surgeries for Benign Prostatic Hyperplasia (BPH).

Who Can Participate

Patients who have had a prostatectomy, radiation for prostate cancer, or surgeries for Benign Prostatic Hyperplasia (BPH) and who are scheduled for the Axonics External Trial System (ETS) who have a primary diagnosis of overactive bladder (OAB) with urinary urge incontinence (UUI) or urinary frequency (UF).